HSF1 and cancer: Our previous researchers found that the abnormal activation of HSF1 promoted the invasion and metastasis of pancreatic cancer, along with the observation that high-level HSF1 correlated with the poor prognosis of many cancers, including pancreatic cancer [7, 8, 38].